Evidence map›Paper›PMID 33071949›Full record

ArticleFrontiers in neurology2020

Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study.

Zheren Tan, Jianlin Jiang, Fafa Tian, Jinxin Peng, Zhiquan Yang, Shuyu Li, Xiaoyan Long

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Investigating the Relationship of Serum CD163, YKL40 and VILIP-1 Levels with Autism Severity and Language-cognitive Development in Preschool Children with Autism.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  3. Biofluid biomarkers for Alzheimer's disease.Frontiers in aging neuroscience · 2024
    Review
  4. Article
  5. Observational
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zheren TanDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Jianlin JiangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Fafa TianDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Jinxin PengDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Zhiquan YangDepartment of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Shuyu LiDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Xiaoyan LongDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkercaveolin-1epilepsyneuronal injuryneuron specific enolasevisinin-like protein 1

Identifiers

PMID33071949
PMCPMC7544981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.